Statistics for Galectin Therapeutics (id:5587 GALT)

Valuation metrics

Market cap

167.53M

Enterprise value

241.35M

Trailing P/E (ttm)

-3.76

Forward P/E

-1.60

PEG ratio

-1.60

Price/Sales (ttm)

Price/Book (mrq)

-1.87

Enterprise Value/Revenue

Enterprise Value/EBITDA

-6.38

Overview

Shares outstanding

62.28M

Float

43.10M

Shares short

5.52M

% Held by insiders

0.31%

% Held by institutions

0.16%

Average volume (10 days)

180.01K

Average volume (90 days)

Price summary

52-Week low

1.56

52-Week high

4.27

52-Week change

23.74%

Beta

0.63

50-Day moving average

2.69

200-Day moving average

2.58

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

March 23th, 2012

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-103.87%

Return on equity

74.38%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

0.00

Net income to common (ttm)

-48,033,000.00

Diluted EPS (ttm)

-0.78

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

25.60M

Total cash per share (mrq)

0.41

Total debt (mrq)

93.46M

Total Debt/Equity (mrq)

-1.01

Current ratio (mrq)

186.70%

Book value per share (mrq)

-1.01

Cash flow

Cash flow statement

-32,777,000.00

Levered free cash flow (LFCF)

-20,357,124.00